BioCentury | Aug 8, 2011
Clinical News

ALX-0081: Interim Phase II data

...showed that ALX-0081 followed by ALX-0681 inhibited vWF-mediated clotting as measured by a reduction in ristocetin cofactor...
BioCentury | Jan 4, 2010
Clinical News

Anti-vWF Nanobody: Extension study data

...trial showed that IV ALX-0081 significantly inhibited vWF-mediated clotting as measured by complete inhibition of ristocetin cofactor...
BioCentury | Aug 24, 2009
Clinical News

ALX-0681: Phase I data

...Phase I trial showed that daily injections of 10 mg ALX-0681 achieved complete inhibition of ristocetin cofactor...
Items per page:
1 - 3 of 3